Stocks
GDR UNITED MEDICAL GROUP GEMC Financial Statements (GEMC) |
||||||||||
| ЕМС | ЮМГsmart-lab.ru | % | 2021Q4 | 2022Q2 | 2022Q4 | 2023Q2 | 2023Q4 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 26.04.2022 | 29.08.2022 | 26.04.2023 | 29.08.2023 | 26.04.2024 | 29.08.2023 | ||||
| Currency | RUB | RUB | RUB | RUB | RUB | RUB | ||||
| Financial report URL | ||||||||||
| Presentation URL | ||||||||||
| Revenue, bln rub | ? | 13.2 | 11.4 | 12.3 | 11.5 | 23.8 | ||||
| Operating Income, bln rub | 3.74 | 3.49 | 2.87 | 3.82 | 6.69 | |||||
| EBITDA, bln rub | ? | 5.15 | 4.32 | 3.75 | 4.74 | 8.49 | ||||
| Net profit, bln rub | ? | 3.37 | 2.73 | 1.94 | 3.28 | 5.22 | ||||
| Net profit not adj., bln rub | ? | 2.61 | -0.330 | 3.60 | 4.48 | 8.08 | ||||
| OCF, bln rub | ? | 5.00 | 3.35 | 3.73 | 4.34 | 8.07 | ||||
| CAPEX, bln rub | ? | 0.410 | 0.220 | 1.07 | 0.700 | 1.77 | ||||
| FCF, bln rub | ? | 4.45 | -0.750 | 6.21 | 3.47 | 9.68 | ||||
| Ordinary share dividend yield, % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0 | ||||
| Dividend payout ratio, % | 0% | 0% | 0% | 0% | 0 | |||||
| OPEX, bln rub | 1.49 | 0.822 | 0.898 | 0.920 | 1.82 | |||||
| Cost of production, bln rub | 8.00 | 7.36 | 8.24 | 6.77 | 15.0 | |||||
| Interest expenses, bln rub | 0.380 | 0.870 | 0.640 | 0.750 | 1.39 | |||||
| Assets, bln rub | 28.6 | 31.4 | 33.0 | 34.0 | 34.0 | |||||
| Net Assets, bln rub | ? | 7.31 | 8.40 | 10.8 | 13.6 | 13.6 | ||||
| Debt, bln rub | 17.2 | 16.6 | 16.9 | 15.8 | 12.6 | 15.8 | ||||
| Cash, bln rub | 2.74 | 2.85 | 4.31 | 6.06 | 3.40 | 6.06 | ||||
| Net debt, bln rub | 14.5 | 13.7 | 12.5 | 9.76 | 9.20 | 9.76 | ||||
| Ordinary share price, rub | 1 003 | 374.6 | 308.3 | 642.5 | 791.7 | 760.0 | ||||
| Number of ordinary shares, mln | 90.0 | 90.0 | 90.0 | 90.0 | 90.0 | 90.0 | ||||
| Market cap, bln rub | 90.3 | 33.7 | 27.7 | 57.8 | 71.3 | 68.4 | ||||
| EV, bln rub | ? | 104.7 | 47.4 | 40.3 | 67.6 | 80.5 | 78.2 | |||
| Book value, bln rub | 5.28 | 2.59 | 10.8 | 13.6 | 0.00 | 13.6 | ||||
| EPS, rub | ? | 37.4 | 30.3 | 21.6 | 36.4 | 0.00 | 58.0 | |||
| FCF/share, rub | 49.4 | -8.33 | 69.0 | 38.6 | 0.00 | 107.6 | ||||
| BV/share, rub | 58.7 | 28.8 | 120.1 | 151.1 | 0.00 | 151.1 | ||||
| EBITDA margin, % | ? | 39.0% | 37.9% | 30.6% | 41.2% | 35.7% | ||||
| Net margin, % | ? | 25.5% | 23.9% | 15.8% | 28.5% | 22.0% | ||||
| FCF yield, % | ? | 9.0% | 11.0% | 19.7% | 16.7% | 4.9% | 14.2% | |||
| ROE, % | ? | 99.5% | 72.6% | 43.2% | 38.4% | 38.4% | ||||
| ROA, % | ? | 25.4% | 19.5% | 14.2% | 15.3% | 15.3% | ||||
| P/E | ? | 12.4 | 5.53 | 5.94 | 11.1 | 21.7 | 13.1 | |||
| P/FCF | 20.3 | -45.0 | 4.47 | 16.7 | 20.5 | 7.07 | ||||
| P/S | ? | 3.57 | 1.37 | 1.17 | 2.43 | 6.19 | 2.88 | |||
| P/BV | ? | 17.1 | 13.0 | 2.57 | 4.25 | 5.03 | ||||
| EV/EBITDA | ? | 10.3 | 5.01 | 4.99 | 7.96 | 17.0 | 9.21 | |||
| Debt/EBITDA | 1.43 | 1.45 | 1.55 | 1.15 | 1.94 | 1.15 | ||||
| Employees, people | 2 004 | |||||||||
| Expenses per employee, thousand rub | 0.00 | |||||||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
| CAPEX/Revenue, % | 3% | 2% | 9% | 6% | 7% | |||||
| GDR UNITED MEDICAL GROUP GEMC shareholders | ||||||||||
